Zepp Health Corporation
ZEPP | NYSE
$4.40
+$0.08 (+1.85%)
Sep 21, 2026, 3:43 PM ET · Market open
Market Data
Market Cap $63.88M
Enterprise Value $1.38B
Beta 1.89
Average Volume 98.35K
Shares Outstanding (Diluted) 989.67K
Shares Change YoY -93.75%
Institutional Ownership N/A
Exchange NYSE
ISIN US98945L2043
Price Performance
Price Change 1M -19.2%
Price Change 3M -7.8%
Price Change 6M -68.0%
Price Change YTD -84.1%
Price Change 1Y -90.4%
Price Change 3Y -1.3%
Price Change 5Y -87.2%
1M CAGR (ann.) -7.1%
1Y CAGR (ann.) -90.9%
5Y CAGR (ann.) -35.8%
All-Time CAGR -23.6%
Valuation
PE Ratio -0.11
Forward PE 1,230.68
PEG Ratio 0.00
Forward PEG 0.00
PS Ratio 0.23
Forward PS 0.20
PB Ratio 0.35
P/FCF Ratio -2.41
P/Adj. FCF Ratio -2.14
P/OCF Ratio -0.17
EV/Sales 0.72
EV/EBIT -5.31
EV/EBITDA -5.50
EV/FCF -7.46
Earnings Yield -980.6%
FCF Yield -43.3%
Adj. FCF Yield -48.9%
Financial Health
Net Debt ¥941.1M
Total Debt ¥1.67B
Cash & Short-Term Investments ¥721.36M
Total Assets ¥3.8B
Current Ratio 0.90
Quick Ratio 0.70
Debt / Equity Ratio 1.33
Debt / EBITDA -6.64
Debt / FCF -9.02
OCF / Debt -0.11
Interest Coverage -5.35
Altman Z-Score 0.21
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 39.1%
Operating Profit Margin -12.4%
EBITDA Margin -13.1%
Net Profit Margin -15.6%
FCF Margin -9.6%
Adj. FCF Margin -10.8%
SBC / Revenue 1.5%
SBC Impact (per share) -12.9%
Returns
Return on Assets -7.9%
Return on Equity -27.9%
Return on Invested Capital -8.1%
Return on Capital Employed -14.4%
Return on Tangible Assets -8.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 55.4%
Revenue CAGR 5Y 12.2%
Revenue CAGR 10Y 46.6%
EPS CAGR 3Y -128.9%
EPS CAGR 5Y -91.1%
EPS CAGR 10Y -54.9%
FCF CAGR 3Y -150.0%
FCF CAGR 5Y -100.0%
FCF CAGR 10Y -244.0%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $12
Price Target Upside 169.1%
Cash Flow
Operating Cash Flow ¥-179.65M
Free Cash Flow ¥-185.14M
Adj. Free Cash Flow ¥-209.01M
FCF Per Share -$187.07
OCF Per Share -$181.53
OCF/S Ratio -9.3%
Income Statement
Revenue ¥1.93B
Gross Profit ¥753.89M
Operating Income ¥-239.59M
EBITDA ¥-251.42M
Net Income ¥-301.48M
EPS (Diluted) -$292.80
Revenue / Employee $2.53M
Profit / Employee $-395.13K
Employees 763
Add to Watchlist
Select watchlists to add or remove ZEPP